BN83495 Phase I in Post-menopausal Women

BN83495 in Prostate Cancer

Evaluation of Palovarotene Concentration in Semen of Healthy Men after Multiple Oral Doses

A Thorough QT Study Evaluating the Effect of a Therapeutic and a Supratherapeutic Dose of Palovarotene on Electrocardiogram Parameters

Study Evaluating the Effect of Food on the Pharmacokinetics of Palovarotene and the Effect of Palovarotene on the Pharmacokinetics of the CYP3A4 Substrate Midazolam in Two Cohorts of Healthy Adult Subjects

MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment

A study to compare the safety and blood levels of Tazemetostat in Participants With Advanced Cancer and Moderate/Severe Liver impairment to Participants with Advanced Cancer and Normal liver function

Study to describe the interaction between tazemetostat and itraconazole and between tazemetostat and rifampin in participants with advanced cancer

Dose Escalation and Dose Expansion Study of IPN60090 in Patients With Advanced Solid Tumours

A study to compare Onivyde manufactured at two different production sites in adult participants with advanced cancer in the pancreas